Among the identified matrix metalloproteinases (MMPs), MMP9 is involved in the progression and metastasis of cervical cancer [23] and ovarian cancer [24], and can be associated with the prognosis and clinicopathological features of CRC [25]. This evidence concerns the gene MMP9 and ovarian cancer.